Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$68.42
-2.1%
$71.43
$58.93
$95.25
$40.22B1.154.63 million shs892,310 shs
Alphabet Inc. stock logo
GOOGL
Alphabet
$154.87
-2.4%
$170.47
$140.53
$207.05
$1.89T1.0332.89 million shs12.30 million shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
+4.21%-3.09%+2.01%-5.80%-24.92%
Alphabet Inc. stock logo
GOOGL
Alphabet
+9.68%+1.06%-4.32%-18.17%+1.35%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
4.5465 of 5 stars
3.23.00.04.03.12.52.5
Alphabet Inc. stock logo
GOOGL
Alphabet
4.5779 of 5 stars
4.43.01.70.03.92.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
2.40
Hold$79.9516.86% Upside
Alphabet Inc. stock logo
GOOGL
Alphabet
2.89
Moderate Buy$207.3833.91% Upside

Current Analyst Ratings Breakdown

Latest EW and GOOGL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
4/10/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$208.00 ➝ $185.00
4/9/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$230.00 ➝ $205.00
4/8/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$220.00 ➝ $180.00
4/1/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Westpark Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/31/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$184.00 ➝ $167.00
3/31/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$235.00 ➝ $200.00
3/27/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$190.00
3/19/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$220.00 ➝ $220.00
3/19/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$200.00 ➝ $200.00
2/13/2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $90.00
(Data available from 4/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$5.44B7.39$2.53 per share27.04$11.08 per share6.17
Alphabet Inc. stock logo
GOOGL
Alphabet
$350.02B5.39$7.95 per share19.49$26.67 per share5.81
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$4.17B$6.979.8224.884.8272.93%19.40%14.37%4/24/2025 (Estimated)
Alphabet Inc. stock logo
GOOGL
Alphabet
$100.12B$8.0519.2415.141.3428.60%32.49%23.52%4/24/2025 (Estimated)

Latest EW and GOOGL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.60N/AN/AN/A$1.40 billionN/A
4/24/2025N/A
Alphabet Inc. stock logo
GOOGL
Alphabet
$2.02N/AN/AN/A$89.30 billionN/A
2/11/2025Q4 2024
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$0.55$0.59+$0.04$0.65$1.36 billionN/A
2/4/2025Q4 2024
Alphabet Inc. stock logo
GOOGL
Alphabet
$2.12$2.15+$0.03$2.15$96.67 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Alphabet Inc. stock logo
GOOGL
Alphabet
$0.800.52%N/A9.94%N/A

Latest EW and GOOGL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/4/2025
Alphabet Inc. stock logo
GOOGL
Alphabet
quarterly$0.200.4%3/10/20253/10/20253/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
0.06
3.46
2.89
Alphabet Inc. stock logo
GOOGL
Alphabet
0.03
1.84
1.84

Institutional Ownership

CompanyInstitutional Ownership
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
79.46%
Alphabet Inc. stock logo
GOOGL
Alphabet
40.03%

Insider Ownership

CompanyInsider Ownership
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
1.29%
Alphabet Inc. stock logo
GOOGL
Alphabet
11.55%
CompanyEmployeesShares OutstandingFree FloatOptionable
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
17,300587.87 million582.19 millionOptionable
Alphabet Inc. stock logo
GOOGL
Alphabet
190,20012.19 billion10.78 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$68.42 -1.48 (-2.12%)
As of 11:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Alphabet stock logo

Alphabet NASDAQ:GOOGL

$154.87 -3.84 (-2.42%)
As of 11:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play and YouTube; and devices, as well as in the provision of YouTube consumer subscription services. The Google Cloud segment offers infrastructure, cybersecurity, databases, analytics, AI, and other services; Google Workspace that include cloud-based communication and collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells healthcare-related and internet services. The company was incorporated in 1998 and is headquartered in Mountain View, California.